These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21400196)

  • 1. Can vitamin D supplementation prevent bone loss in persons with MS? A placebo-controlled trial.
    Steffensen LH; Jørgensen L; Straume B; Mellgren SI; Kampman MT
    J Neurol; 2011 Sep; 258(9):1624-31. PubMed ID: 21400196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No significant effect on bone mineral density by high doses of vitamin D3 given to overweight subjects for one year.
    Jorde R; Sneve M; Torjesen PA; Figenschau Y; Hansen JB; Grimnes G
    Nutr J; 2010 Jan; 9():1. PubMed ID: 20056003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial.
    Holmøy T; Lindstrøm JC; Eriksen EF; Steffensen LH; Kampman MT
    BMC Neurol; 2017 Apr; 17(1):67. PubMed ID: 28376767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial.
    Cooper C; Harvey NC; Bishop NJ; Kennedy S; Papageorghiou AT; Schoenmakers I; Fraser R; Gandhi SV; Carr A; D'Angelo S; Crozier SR; Moon RJ; Arden NK; Dennison EM; Godfrey KM; Inskip HM; Prentice A; Mughal MZ; Eastell R; Reid DM; Javaid MK;
    Lancet Diabetes Endocrinol; 2016 May; 4(5):393-402. PubMed ID: 26944421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial.
    Kampman MT; Steffensen LH; Mellgren SI; Jørgensen L
    Mult Scler; 2012 Aug; 18(8):1144-51. PubMed ID: 22354743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized double-blind placebo-controlled trial of vitamin D supplementation in juvenile-onset systemic lupus erythematosus: positive effect on trabecular microarchitecture using HR-pQCT.
    Lima GL; Paupitz JA; Aikawa NE; Alvarenga JC; Pereira RMR
    Osteoporos Int; 2018 Mar; 29(3):587-594. PubMed ID: 29152675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of high-dose vitamin D
    Larsen AU; Grimnes G; Jorde R
    Osteoporos Int; 2018 Jan; 29(1):171-180. PubMed ID: 28921338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass--a randomized controlled 1-year trial.
    Grimnes G; Joakimsen R; Figenschau Y; Torjesen PA; Almås B; Jorde R
    Osteoporos Int; 2012 Jan; 23(1):201-11. PubMed ID: 21909730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of monthly 50,000 IU or 100,000 IU vitamin D supplements on vitamin D status in premenopausal Middle Eastern women living in Auckland.
    Mazahery H; Stonehouse W; von Hurst PR
    Eur J Clin Nutr; 2015 Mar; 69(3):367-72. PubMed ID: 25491499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An initial loading-dose vitamin D versus placebo after hip fracture surgery: randomized trial.
    Mak JC; Mason RS; Klein L; Cameron ID
    BMC Musculoskelet Disord; 2016 Aug; 17():336. PubMed ID: 27515154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D supplementation increases calcium absorption without a threshold effect.
    Aloia JF; Dhaliwal R; Shieh A; Mikhail M; Fazzari M; Ragolia L; Abrams SA
    Am J Clin Nutr; 2014 Mar; 99(3):624-31. PubMed ID: 24335055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and safety of vitamin D in relation to bone health.
    Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
    Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial.
    Havens PL; Stephensen CB; Van Loan MD; Schuster GU; Woodhouse LR; Flynn PM; Gordon CM; Pan CG; Rutledge B; Harris DR; Price G; Baker A; Meyer WA; Wilson CM; Hazra R; Kapogiannis BG; Mulligan K;
    Clin Infect Dis; 2018 Jan; 66(2):220-228. PubMed ID: 29020329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial.
    Cheung AM; Tile L; Cardew S; Pruthi S; Robbins J; Tomlinson G; Kapral MK; Khosla S; Majumdar S; Erlandson M; Scher J; Hu H; Demaras A; Lickley L; Bordeleau L; Elser C; Ingle J; Richardson H; Goss PE
    Lancet Oncol; 2012 Mar; 13(3):275-84. PubMed ID: 22318095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Vitamin D Supplements Increase Serum 25-Hydroxyvitamin D in Postmenopausal Women and Reduce Bone Calcium Flux Measured by 41Ca Skeletal Labeling.
    Schild A; Herter-Aeberli I; Fattinger K; Anderegg S; Schulze-König T; Vockenhuber C; Synal HA; Bischoff-Ferrari H; Weber P; von Eckardstein A; Zimmermann MB
    J Nutr; 2015 Oct; 145(10):2333-40. PubMed ID: 26338885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial.
    Overton ET; Chan ES; Brown TT; Tebas P; McComsey GA; Melbourne KM; Napoli A; Hardin WR; Ribaudo HJ; Yin MT
    Ann Intern Med; 2015 Jun; 162(12):815-24. PubMed ID: 26075752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65-71 years: a 3-year randomized population-based trial (OSTPRE-FPS).
    Kärkkäinen M; Tuppurainen M; Salovaara K; Sandini L; Rikkonen T; Sirola J; Honkanen R; Jurvelin J; Alhava E; Kröger H
    Osteoporos Int; 2010 Dec; 21(12):2047-55. PubMed ID: 20204604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 16-weeks vitamin D replacement on calcium-phosphate homeostasis in overweight and obese adults.
    Mesinovic J; Mousa A; Wilson K; Scragg R; Plebanski M; de Courten M; Scott D; Naderpoor N; de Courten B
    J Steroid Biochem Mol Biol; 2019 Feb; 186():169-175. PubMed ID: 30367939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of risedronate with cholecalciferol on bone mineral density in Korean patients with osteoporosis.
    Park SY; Kang MI; Park HM; Rhee Y; Moon SH; Yoon HK; Koh JM; Chang JS; Kim IJ; Won YY; Park YS; Choi H; Shin CS; Yoon TR; Yun SC; Chung HY;
    Arch Osteoporos; 2019 Dec; 15(1):3. PubMed ID: 31820121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mass preservation with high-dose cholecalciferol and dietary calcium in HIV patients following antiretroviral therapy. Is it possible?
    Mela Q; Ruggiero V; Montaldo L; Pisano U; Matta L; Maria Pasetto C; Onali S; Cacace E; Carta MG; Barca L; Chessa L
    HIV Clin Trials; 2018 Oct; 19(5):188-196. PubMed ID: 30445888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.